Calix (CXL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
24 Feb, 2026Executive summary
Achieved strong revenue and gross profit growth in 1H FY26, with magnesia revenue up 48% year-over-year and group product & services revenue up 21% compared to 1H FY25, driven by the magnesia business and initial contributions from sustainable processing.
Operating expenses reduced by 30% year-over-year, with disciplined cost management, streamlined operations, and a capital-light business model.
Significant commercial milestones reached, including a major U.S. magnesia contract, Rio Tinto partnership, and completion of the lithium Mid-Stream Demonstration Plant.
A $30.2m non-cash impairment was recorded due to the planned sale of the Midstream project stake, resulting in a net loss of $42.8m for the period.
Net cash used in operating activities decreased to $6.2m, and cash and equivalents were $11.8m at 31 December 2025.
Financial highlights
Product and services revenue reached AUD 16.3 million (up 21% year-over-year); magnesia revenue AUD 15.8 million (up 48%).
Gross profit increased 37% to AUD 6.7 million, with gross margin rising to 40% from 37% year-over-year.
Operating expenditure down 30% to AUD 15.6 million; net cash used in operating activities down 65% to AUD 6.2 million.
CapEx spend reduced to AUD 600,000 (excluding Mid-Stream Project share); total CapEx $7.1m, focused on Magnesia and Midstream projects.
Net loss for the period was $42.8m, driven by a $30.2m impairment related to the Midstream project sale.
Outlook and guidance
Expecting cash flow neutrality in calendar year 2026, driven by continued revenue and gross profit growth, reduced OpEx, and minimal CapEx, excluding anticipated $11.4m cash payment from PLS.
Anticipate additional cash inflows from government grants, project milestones, R&D tax incentives, and the sale of the Midstream project stake.
Major new magnesia contract to begin contributing in the second half, with ramp-up expected over several months.
Focus on progressing ZESTY to final investment decision and advancing key projects in alumina and lime.
Directors consider the group a going concern based on current forecasts and cost controls.
Latest events from Calix
- Revenue up 30% and gross margin at 43% as key projects and new grants drive growth.CXL
H2 202412 Feb 2026 - Revenue up 11% to $13.5m; cost savings, grants, and projects extend cash runway and outlook.CXL
H1 202512 Feb 2026 - Revenue up 11% to $33.9m, costs down 23%, and cash runway extended to 18 months.CXL
H2 202512 Feb 2026 - ZESTY and Leilac advance scalable, low-emission solutions for steel and cement industries.CXL
Status Update1 Feb 2026 - Cost discipline, project focus, and strong shareholder support drive future growth.CXL
AGM 202412 Jan 2026 - Strong revenue growth and major decarbonisation projects drive robust shareholder support.CXL
AGM 202518 Nov 2025 - $44.9M ARENA grant advances flexible, low-emission ironmaking tech toward 2028 launch.CXL
Status Update16 Nov 2025 - Energy-flexible kiln tech drives 11% revenue growth and global awards as key projects advance.CXL
Status Update12 Nov 2025 - Award-winning technology drives decarbonisation and electrification across global industries.CXL
Investor Presentation20 Oct 2025